BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 26, 2021
View Archived Issues
Benefit seen with tipifarnib in HRAS-mutant head and neck squamous cell carcinoma
Read More
Heartseed to initiate phase I/II LAPiS study of iPSC-derived cardiomyocyte spheroids
Read More
Data on weekly basal insulin LY-3209590 in patients with T2D presented
Read More
Vasomune provides preliminary phase I data for AV-001
Read More
GlaxoSmithKline initiates first-in-human study of GSK-4108771A
Read More
IMPACT Therapeutics synthesizes CHK1 inhibitors
Read More
Ono Pharmaceutical and Pharmaron Beijing patent DDR1 inhibitors
Read More
Chengdu Synowest Biotechnology discloses CDK inhibitors
Read More
Sunshine Lake Pharma presents new RET inhibitors
Read More
Enrollment ongoing in phase III study of LOXO-305 in MCL
Read More
New LECT2-targeting compounds identified by Alnylam Pharmaceuticals
Read More
Endocannabinoids act on astrocytes to prevent tremor
Read More
Safety and QoL data from phase III monarchE study of ET therapy with or without abemaciclib
Read More
DKN-01 demonstrates activity in gynecologic cancers with Wnt activating mutations
Read More
Japanese approval of Isturisa for endogenous Cushing's syndrome
Read More
RZ-358 shows promise for treating PGBH
Read More
Dual EBV oncoprotein targeting using upconversion nanomaterials for cancer monitoring and treatment
Read More
Multiple dosing of Lassa fever candidate LHF-535 well tolerated in healthy subjects
Read More
Depletion of DNA polymerase beta increases platinum sensitivity in epithelial ovarian cancers
Read More
FDA approves Myrbetriq tablets and granules for neurogenic detrusor overactivity in children
Read More
First-in-human data presented for SRP-9003 in patients with limb girdle muscular dystrophy type 2E
Read More
Sorrento reports further phase Ib data on COVI-MSC for COVID-19-induced ARDS
Read More
FDA accepts IND for phase Ib study of AT-100 for bronchopulmonary dysplasia
Read More
Chinese phase III trial of LY-03005 for major depressive disorder meets endpoints
Read More
Anaveon gains CTA clearance for phase I/II study of ANV-419 in advanced solid tumors
Read More
